反応式
[Cl:1][C:2]1[C:7]([C:8]#[N:9])=[CH:6][C:5]([F:10])=[C:4](Cl)[N:3]=1.Cl.[NH2:13][CH:14]([CH2:18][C:19]([F:22])([F:21])[F:20])[C:15]([NH2:17])=[O:16].CCN(C(C)C)C(C)C.O>CS(C)=O.CCOC(C)=O>[Cl:1][C:2]1[N:3]=[C:4]([NH:13][CH:14]([CH2:18][C:19]([F:22])([F:21])[F:20])[C:15]([NH2:17])=[O:16])[C:5]([F:10])=[CH:6][C:7]=1[C:8]#[N:9]参加物
7
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
A solution of 2,6-dichloro-3-cyano-5-fluoropyridine (134 mg, 0.701 mmol), 2-amino-4,4,4-trifluorobutanamide hydrochloride (135 mg, 0.701 mmol) and DIEA (0.365 mL, 2.10 mmol) in DMSO (3 mL) was stirred at 95 C for 3 h. Water and EtOAc were added. The organic phase was separated, dried over Na2SO4, concentrated in vacuo to give crude 2-(6-chloro-5-cyano-3-fluoropyridin-2-ylamino)-4,4,4-trifluorobutanamide (218 mg).
後処理
- customThe organic phase was separated
- dry with materialdried over Na2SO4
- concentrationconcentrated in vacuo
出典と根拠
- ORDレコード
- ord-79fcec32ad3942c5970dbc61cdb6b006
- 出典データセット
- uspto-grants-2014_09
- 特許番号
- US08846928B2
関連ノート
読み込み中…